161 related articles for article (PubMed ID: 20651316)
1. Decrease in serum valproic acid levels during treatment with ertapenem.
Liao FF; Huang YB; Chen CY
Am J Health Syst Pharm; 2010 Aug; 67(15):1260-4. PubMed ID: 20651316
[TBL] [Abstract][Full Text] [Related]
2. Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy.
Lunde JL; Nelson RE; Storandt HF
Pharmacotherapy; 2007 Aug; 27(8):1202-5. PubMed ID: 17655519
[TBL] [Abstract][Full Text] [Related]
3. Meropenem -valproic acid interaction in patients with cefepime-associated status epilepticus.
Spriet I; Meersseman W; De Troy E; Wilmer A; Casteels M; Willems L
Am J Health Syst Pharm; 2007 Jan; 64(1):54-8. PubMed ID: 17189580
[TBL] [Abstract][Full Text] [Related]
4. Acute seizures due to a probable interaction between valproic acid and meropenem.
Coves-Orts FJ; Borrás-Blasco J; Navarro-Ruiz A; Murcia-López A; Palacios-Ortega F
Ann Pharmacother; 2005 Mar; 39(3):533-7. PubMed ID: 15701769
[TBL] [Abstract][Full Text] [Related]
5. A critical interaction between ertapenem and valproic acid.
Molnar GP; Stephens KJ; George LV; Stewart JT
J Clin Psychopharmacol; 2015 Jun; 35(3):348-50. PubMed ID: 25871574
[No Abstract] [Full Text] [Related]
6. Unusual drug reaction between valproate sodium and meropenem.
Yoon H; Kim DH
Int J Clin Pharm; 2013 Jun; 35(3):316-8. PubMed ID: 23483443
[TBL] [Abstract][Full Text] [Related]
7. Ertapenem-associated seizures in a patient without prior CNS disorder or severe renal dysfunction.
Soštaric N; Beovic B; Maticic M
Int J Clin Pharmacol Ther; 2014 Mar; 52(3):255-8. PubMed ID: 24472405
[TBL] [Abstract][Full Text] [Related]
8. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem.
Fudio S; Carcas A; Piñana E; Ortega R
J Clin Pharm Ther; 2006 Aug; 31(4):393-6. PubMed ID: 16882111
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations.
Wu CC; Pai TY; Hsiao FY; Shen LJ; Wu FL
Ther Drug Monit; 2016 Oct; 38(5):587-92. PubMed ID: 27322166
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage.
Mink S; Muroi C; Seule M; Bjeljac M; Keller E
Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756
[TBL] [Abstract][Full Text] [Related]
11. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient.
Gu J; Huang Y
Am J Geriatr Pharmacother; 2009 Feb; 7(1):26-33. PubMed ID: 19281938
[TBL] [Abstract][Full Text] [Related]
12. High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapy.
de Maat MM; van Leeuwen HJ; Edelbroek PM
Ann Pharmacother; 2011 Mar; 45(3):e18. PubMed ID: 21325101
[TBL] [Abstract][Full Text] [Related]
13. Interaction between valproic acid and meropenem or ertapenem in patients with epilepsy: clinical relevance and results from pharmaceutical intervention.
Hernández-Ramos JA; Caro-Telle JM; Bruni-Montero MÁ; Canales-Siguero D; Ferrari-Piquero JM
Farm Hosp; 2021 Sep; 45(6):335-339. PubMed ID: 34806574
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of ertapenem in the treatment of early ventilator-associated pneumonia caused by extended-spectrum beta-lactamase-producing organisms in an intensive care unit.
Bassetti M; Righi E; Fasce R; Molinari MP; Rosso R; Di Biagio A; Mussap M; Pallavicini FB; Viscoli C
J Antimicrob Chemother; 2007 Aug; 60(2):433-5. PubMed ID: 17540673
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with the development of seizures among adult patients treated with ertapenem: A matched case-control study.
Lee YC; Huang YJ; Hung MC; Hung SC; Hsiao CY; Cho HL; Lai LF; Tong SH; Wang JT
PLoS One; 2017; 12(7):e0182046. PubMed ID: 28759588
[TBL] [Abstract][Full Text] [Related]
16. The impact of ertapenem use on the susceptibility of Pseudomonas aeruginosa to imipenem: a hospital case study.
Lima AL; Oliveira PR; Paula AP; Dal-Paz K; Rossi F; Zumiotti AV
Infect Control Hosp Epidemiol; 2009 May; 30(5):487-90. PubMed ID: 19335227
[TBL] [Abstract][Full Text] [Related]
17. Potential interaction between valproic acid and doripenem.
Hellwig TR; Onisk ML; Chapman BA
Curr Drug Saf; 2011 Feb; 6(1):54-8. PubMed ID: 21241241
[TBL] [Abstract][Full Text] [Related]
18. Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates.
Pires dos Santos R; Jacoby T; Pires Machado D; Lisboa T; Gastal SL; Nagel FM; Kuplich NM; Konkewicz L; Gorniak Lovatto C; Pires MR; Goldani LZ
Infect Control Hosp Epidemiol; 2011 Jun; 32(6):584-90. PubMed ID: 21558771
[TBL] [Abstract][Full Text] [Related]
19. The effect of hemodialysis and hemoperfusion on serum valproic acid concentration.
Kandrotas RJ; Love JM; Gal P; Oles KS
Neurology; 1990 Sep; 40(9):1456-8. PubMed ID: 2118241
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid-induced hyperammonemia and thrombocytopenia in an elderly woman.
Mallet L; Babin S; Morais JA
Ann Pharmacother; 2004 Oct; 38(10):1643-7. PubMed ID: 15316109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
